Most Read

Under the terms of the deal, CD&R will pay £10.23 in cash per share in UDG. Headquartered in Dublin, UDG Healthcare provide healthcare advisory, communications, commercial, clinical and

The companies will leverage MiNA Therapeutics’ small activating RNA (saRNA) technology platform to develop the drug candidates. Using its saRNA platform, MiNA Therapeutics will research up to five

The US Food and Drug Administration (FDA) has expanded the emergency use authorisation (EUA) for Pfizer and BioNTech’s Covid-19 vaccine to include adolescents aged 12 to 15 years.

India’s Defence Research and Development Organisation (DRDO) lab Institute of Nuclear Medicine and Allied Sciences (INMAS) developed the drug in alliance with Dr Reddy’s Laboratories (DRL). The drug

The Russian Direct Investment Fund (RDIF) has announced that a single dose Covid-19 vaccine called Sputnik Light, obtained authorisation for use in the country. With recombinant human adenovirus

Pfizer Canada and BioNTech have received Interim Order authorisation from Health Canada for the use of their Covid-19 vaccine in adolescents aged 12 to 15 years. This Covid-19

World Health Organization (WHO) has granted emergency use listing (EUL) for Moderna’s Covid-19 vaccine to prevent the infection in people aged 18 years and above. The Covid-19 Vaccine

Pharmaceutical company Pfizer has acquired  a privately held company Amplyx Pharmaceuticals for an undisclosed amount. Amplyx is developing treatment for life-threatening diseases caused due to failing immune system.

Merck, called as MSD outside the US and Canada, has signed voluntary licensing agreements with five Indian generic drug makers to expand access to Molnupiravir, an experimental oral